Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Clinical Study of Helicobacter Pylori 23S rRNA/gyrA Gene Mutation Detection Kit (Fluorescence PCR Fusion Curve Method)

NCT05410652 is registered in ClinicalTrials.gov with Nanjing First Hospital, Nanjing Medical University as lead sponsor.

NCT NCT05410652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05410652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Clinical Study of Helicobacter Pylori 23S rRNA/gyrA Gene Mutation Detection Kit (Fluorescence PCR Fusion Curve Method)
Lead sponsor
Nanjing First Hospital, Nanjing Medical University
Phase
Observational
Overall status
Completed
Start date
August 1, 2022
Completion date
October 1, 2023
Enrollment
1,176 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

fecal drug resistance gene detection, helicobacter pylori gyra levofloxacin resistance mutation, helicobacter pylori infection, helicobacter pylori infection, susceptibility to